EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mitoxantrone‐Encapsulated ZIF‐8 Enhances Chemo‐Immunotherapy via Amplified Immunogenic Cell Death

Junhong Li, Wenxing Lv, Ziwei Han, Yike Li, Jinqi Deng, Yanjuan Huang, Shuo Wan, Jiashu Sun iD, Bo Dai

Advanced Science · 2025-04 · 12 (14)

DOI: 10.1002/advs.202501542 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 14.02.2025. Verfasst von Junhong Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China. Hauptthemen laut MEDLINE: Mitoxantrone, Immunotherapy, Zeolites, Immunogenic Cell Death. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Nature Science Foundation of China, Discipline Leader Project of Shanghai Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemo‐immunotherapy, combining systemic chemotherapeutic drugs and immune checkpoint blockers, is a promising paradigm in cancer treatment. However, challenges such as limited induction of immune responses and systemic immune toxicity have hindered its clinical applications. Here, a zeolite imidazolate framework‐8 (ZIF‐8) that encapsulates mitoxantrone (MIT), an immune cell death (ICD)‐inducing chemotherapeutic agent (MIT@ZIF‐8), is synthesized using a one‐pot aqueous‐phase process. ZIF‐8 serves as a dual‐functional nanomaterial for chemo‐immunotherapy: a carrier to enhance tumor uptake of MIT for improved chemotherapy efficacy, and a pyroptosis inducer to amplify MIT‐induced ICD for augmented anti‐tumor immune responses. As a result, in vivo administration of MIT@ZIF‐8 markedly inhibits tumor growth in both immunologically “hot” colon cancer and immunologically “cold” prostate cancer. Moreover, MIT@ZIF‐8 treatment increases the abundance of cytotoxic CD8 + T cells and reduces the amount of immunosuppressive regulatory T cells in tumors, thereby enhancing anti‐tumor immunity and sensitizing prostate cancer to anti‐CTLA‐4 immunotherapy. In summary, MIT@ZIF‐8 offers a highly translational approach for chemo‐immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitoxantroneImmunotherapyZeolitesImmunogenic Cell DeathAntineoplastic AgentsProstatic NeoplasmsAnimalsMiceHumansCell Line, TumorMaleColonic Neoplasms

Stichwörter der Autor:innen

chemo‐immunotherapyimmunogenic cell deathprostate cancerpyroptosiszeolitic imidazolate framework‐8

Substanzen

MitoxantroneZeolitesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, P. R. China.
  • Beijing Engineering Research Center for BioNanotechnology, CAS Key Laboratory of Standardization and Measurement for Nanotechnology, National Center for Nanoscience and Technology, Beijing, 100190, P. R. China.
  • School of Future Technology, University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.
  • Foundation for Applied Molecular Evolution, Alachua, Florida, 32615, US.

ORCID-Profile: Jiashu Sun

Förderung

  • National Key R&D Program of China
  • National Nature Science Foundation of China
  • Discipline Leader Project of Shanghai Municipal Health Commission
  • CAS Project for Young Scientists in Basic Research
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Li, J., Lv, W., Han, Z., Li, Y., Deng, J., Huang, Y., Wan, S., Sun, J., & Dai, B. (2025). Mitoxantrone‐Encapsulated ZIF‐8 Enhances Chemo‐Immunotherapy via Amplified Immunogenic Cell Death. Advanced Science, 12(14). https://doi.org/10.1002/advs.202501542

Vancouver

Li J, Lv W, Han Z, Li Y, Deng J, Huang Y, et al. Mitoxantrone‐Encapsulated ZIF‐8 Enhances Chemo‐Immunotherapy via Amplified Immunogenic Cell Death. Advanced Science. 2025;12(14). doi:10.1002/advs.202501542

BibTeX
@article{Li2025,
  author = {Li, Junhong and Lv, Wenxing and Han, Ziwei and Li, Yike and Deng, Jinqi and Huang, Yanjuan and Wan, Shuo and Sun, Jiashu and Dai, Bo},
  title = {Mitoxantrone‐Encapsulated ZIF‐8 Enhances Chemo‐Immunotherapy via Amplified Immunogenic Cell Death},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {14},
  doi = {10.1002/advs.202501542}
}
Kostenlos starten →